298 291

Cited 0 times in

공고요법까지 관해상태를 유지한 소아 급성골수성백혈병에서 자가조혈모세포이식의 치료 효과 비교

Other Titles
 Comparative Results of Autologous Hematopoietic Stem Cell Transplantation in Childhood Acute Myeloid Leukemia Patients with Continuous Complete Remission during Consolidation Chemotherapy 
Authors
 최성열  ;  김남균  ;  권승연  ;  한정우  ;  원성철  ;  유철주 
Citation
 Clinical Pediatric Hematology-Oncology (임상소아혈액종양), Vol.14(2) : 159-166, 2007 
Journal Title
 Clinical Pediatric Hematology-Oncology (임상소아혈액종양) 
ISSN
 2233-5250 
Issue Date
2007
Abstract
Purpose: In many studies, allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is the most effective treatment of acute myeloid leukemia (AML). Autologous hematopoietic stem cell transplantation (Auto-HSCT) is another choice of treatment in patients who do not have an HLA matched donor. But overall results comparing Auto-HSCT to Allo-HSCT and chemotherapy only have been inconsistent. We report the results of Auto-HSCT in childhood AML patients. Methods: From the retrospectively maintained database at the Pediatric Department of Severance Hospital, we identified patients less than 15 years of age. They achieved remission and continuous complete remission during consolidation chemotherapy. They were treated with Auto-HSCT, Allo-HSCT or chemotherapy only. Event-free-survival (EFS) rates were estimated by the method of Kaplan and Meier, and confidence intervals were calculated using log-rank test. Results: 16 children with AML who achieved remission and continuous complete remission during consolidation chemotherapy were selected. They were eligible for allocation to Allo-HSCT (n=7) or to Auto-HSCT (n=5) or chemotherapy only (n=4). EFS of 3 years is as follows: Allo-HSCT, 71.4%±17.1%; Auto-HSCT, 100%; and chemotherapy only, 25%±22%. EFS in Auto-HSCT is significantly superior to chemotherapy only (P=0.04). Differences between Auto-HSCT and Allo-HSCT are not significant (P=0.21). Conclusion: When patients with AML who achieved remission and continuous complete remission during consolidation chemotherapy had no HLA matched donor, Auto-HSCT was a more effective therapy than chemotherapy only and had similar effectiveness with Allo-HSCT.
Files in This Item:
T200700879.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers
Yonsei Authors
Lyu, Chuhl Joo(유철주) ORCID logo https://orcid.org/0000-0001-7124-7818
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/97024
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse